Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
7.00
+0.01 (0.14%)
At close: May 12, 2025, 4:00 PM
7.20
+0.20 (2.86%)
After-hours: May 12, 2025, 7:39 PM EDT

Rocket Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
7541,3122,7021,4811,4073,322
Upgrade
Market Cap Growth
-70.83%-51.45%82.43%5.29%-57.65%169.40%
Upgrade
Enterprise Value
4611,1022,2901,1971,0083,162
Upgrade
Last Close Price
7.0012.5729.9719.5721.8354.84
Upgrade
PB Ratio
1.812.835.493.033.096.60
Upgrade
P/TBV Ratio
2.173.296.313.493.327.03
Upgrade
Debt / Equity Ratio
0.060.060.050.050.050.12
Upgrade
Quick Ratio
9.019.157.699.1017.5414.80
Upgrade
Current Ratio
9.199.307.809.3017.6914.94
Upgrade
Return on Equity (ROE)
-60.45%-54.14%-50.01%-46.98%-35.29%-34.46%
Upgrade
Return on Assets (ROA)
-34.80%-31.21%-28.69%-26.68%-19.10%-17.43%
Upgrade
Return on Capital (ROIC)
-37.33%-33.93%-31.14%-28.27%-19.93%-18.25%
Upgrade
Earnings Yield
-34.21%-19.73%-9.09%-14.98%-12.02%-4.21%
Upgrade
FCF Yield
-28.22%-16.43%-7.82%-12.59%-9.15%-2.87%
Upgrade
Buyback Yield / Dilution
-13.04%-12.85%-23.27%-7.77%-14.18%-13.00%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q